CD8A and neoplasm: Conversely, tumor infiltrating CD8 T cells had higher levels of CTLA-4 expression in α-PD-L1 mAb blockade treated mice, suggesting that tumor cells may be directly or indirectly using this pathway to suppress CTL-mediated killing (Figure 1D).